CircRNA-encoded RIPK1-98 protein drives lung adenocarcinoma progression
Authors:
- 12 March 2026
- journal article
- Published by Elsevier in Developmental Cell
- Vol. 61 (5) , 1092-1110.e12
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- A pathological role of O-GlcNAcylation-driven TR11B production and function in lung adenocarcinomaDevelopmental Cell, 2025
- Mitochondrial CCN1 drives ferroptosis via fatty acid β-oxidationDevelopmental Cell, 2025
- Differences of molecular events driving pathological and radiological progression of lung adenocarcinomaEBioMedicine, 2023
- Ultrafast one‐pass FASTQ data preprocessing, quality control, and deduplication using fastpiMeta, 2023
- MEKs/ERKs-mediated FBXO1/E2Fs interaction interference modulates G1/S cell cycle transition and cancer cell proliferationArchives of Pharmacal Research, 2023
- MORTALIN-Ca2+ axis drives innate rituximab resistance in diffuse large B-cell lymphomaCancer Letters, 2022
- A novel protein encoded by circASK1 ameliorates gefitinib resistance in lung adenocarcinoma by competitively activating ASK1-dependent apoptosisCancer Letters, 2021
- Circular RNA circβ‐catenin aggravates the malignant phenotype of non‐small‐cell lung cancer via encoding a peptideJournal of Clinical Laboratory Analysis, 2021
- Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunityJournal of Controlled Release, 2021
- The Role of Non-coding RNAs in OncologyCell, 2019